Komori
Zeria Pharmaceutical (4559) · TargetRaised

Female managers to account for 10% by the end of fiscal 2023

First written in FY2023. 1 of 4 entries say "Softened", first in FY2024. Latest entry: FY2026.

4entries
4years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2023SoftenedFY2024AdvancedFY2025 – FY20262023: 120232024: 120242025: 120252026: 12026
Same theme, other companies
Stand-alone target for the proportion of women in managementA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2026RaisedAnnual report

    「The proportion of female employees in managerial positions was 11.1% as of the end of March 2026, achieving the target of at least 10% for the end of fiscal 2025, and we have set a target of at least 12% by the end of fiscal 2028」

    The previous target of at least 10% for the proportion of female managers was achieved, with the proportion reaching 11.1%, and the next target was raised to at least 12% by the end of fiscal 2028.
  2. FY2025AdvancedAnnual report

    「We have set a target of increasing the proportion of female employees in management positions to 10% by the end of fiscal 2026 and continue to develop and improve internal systems and the workplace environment.」

    The target of a 10% proportion of female managers by the end of fiscal 2026 was maintained, and the proportion at the filing company was 9.8% as of the end of March 2025.
  3. FY2024SoftenedAnnual report

    「We aim to increase the proportion of female employees in management positions to 10% by the end of fiscal 2026 and are working to develop and improve internal systems and the workplace environment.」

    The numerical target of a 10% proportion of female managers has been maintained, but the deadline was extended from the previous target of the end of fiscal 2023 to the end of fiscal 2026. The proportion was 9.1% as of the end of March 2024.
  4. FY2023First statedAnnual report

    「With the goal of increasing the proportion of women in management positions to 10% by the end of fiscal 2023, we are promoting work-style reforms and initiatives including developing flextime and telecommuting systems, supporting employees with childcare and nursing care responsibilities, and promoting the employment of older people and people with disabilities.」

    The company set a target of a 10% proportion of female managers by the end of fiscal 2023 and identified work-style reforms, flexible work arrangements, and childcare and nursing care support as measures.
Moved together

"Initiative to make Vietnam a base for expanding the Asian business" moved the same way as this thread, in the same document, in 3 of its 4 moves.

322222★123456
  1. ★This thread
  2. 1Initiative to make Vietnam a base for expanding the Asian business3×
  3. 2Stable and Consistent Dividends and Strengthening Retained Earnings2×
  4. 3Strengthening the Foundation as a Global Company2×
  5. 4Growth of the Prescription Pharmaceutical Business Driven by Asacol, Acofide, and Entocort2×
  6. 5Enhancing the New Drug Pipeline and Consumer Healthcare Products2×
  7. 6Progress in Clinical Trials and Regulatory Filings for Multiple Products2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Zeria Pharmaceutical's next results are scheduled for 2026-11-04. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.